Laponia Innovatio AB has developed and patented a needle protection solution for diabetics that eliminates the risk of needlestick injuries arising from subcutaneous insulin use. The product also prevents needle reuse. Developed in close cooperation with health, product and industry specialists, the needle protection solution meets EU directive 2010/32/EU, ensuring high safety standards are met. Importantly, this innovation overcomes the need to recap needles; the cause of many needlestick injuries.
User friendly - simple and efficient
Single use and no recapping
Easy to use with one hand
Designed for scalable production and efficient logistics
Needlestick protection consists of a cannula with a pre-assembled cap to be screwed on the insulin pen. The cannula can be used on all insulin pens. After insulin administration, the soft and flexible needle design allows one hand to be used to cap the needle ready for safe disposal in a sharps receptacle.
The target user group for the product is primarily diabetics and health care professionals working for municipal and county councils.
Needlestick injuries present serious health risks associated with insulin administration and when recapping is performed, frequently under time pressure, leading to stress. The consequences of needlestick injuries for health care professionals and the community at large include concern for disease transmission and costs of rehabilitation.
1.2 million needlestick injuries occurs every year in the EU.
Each diabetic uses 2-6 needles per day.
The number of insulin-treated diabetes patients in Europe is estimated to be approximately 14 million (2017).
Oskar Stenberg CEO firstname.lastname@example.org +46 70-602 59 90
Margareta Matiasson Founder/Owner email@example.com +46 70-655 93 40